GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BUE:MRK) » Definitions » Cash Flow for Dividends

Merck (BUE:MRK) Cash Flow for Dividends : ARS-2,136,189 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Merck Cash Flow for Dividends?

Merck's cash flow for dividends for the three months ended in Dec. 2023 was ARS-668,572 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2023 was ARS-2,136,189 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Merck's quarterly payment of dividends increased from Jun. 2023 (ARS-452,400 Mil) to Sep. 2023 (ARS-649,157 Mil) and increased from Sep. 2023 (ARS-649,157 Mil) to Dec. 2023 (ARS-668,572 Mil).

Merck's annual payment of dividends increased from Dec. 2021 (ARS-667,544 Mil) to Dec. 2022 (ARS-1,175,562 Mil) and increased from Dec. 2022 (ARS-1,175,562 Mil) to Dec. 2023 (ARS-2,687,645 Mil).


Merck Cash Flow for Dividends Historical Data

The historical data trend for Merck's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Cash Flow for Dividends Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -340,410.65 -505,776.68 -667,543.89 -1,175,561.77 -2,687,645.00

Merck Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -293,387.49 -366,060.16 -452,400.00 -649,157.27 -668,572.00

Merck Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS-2,136,189 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Merck's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck (BUE:MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (BUE:MRK) Headlines

From GuruFocus

Merck Announces Second-Quarter 2024 Dividend

By Business Wire 01-23-2024

Q1 2023 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc at ASCO Annual Meeting Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc Investor Event at ACC.23/WCC Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024